The overall goal of this proposed project is to understand the mechanism of regulation of human BRCA2 gene expression in order to explore the possibility of epigenetic malfunction in this mechanism, which may lead to sporadic breast cancer. Recently, we have found an Alu-repeat containing transcriptional silencer at the upstream of human BRCA2. This silencer is active only in the quiescent cells but not in the dividing breast cells. The mechanisms of the activation and inactivation of this silencer in the quiescent and dividing cells, respectively, are presently unknown. We have shown that specific nuclear proteins, from quiescent breast cell nuclear extract sequence-specifically binds to this silencer. Understanding the structure-activity relationships in these bindings in reference to covalent modifications of the DNA elements and the protein factors may reveal the mechanisms of the regulation of the silencer function. Our hypothesis is that the human BRCA2 gene is silenced in the quiescent stage of breast cells but is activated in the dividing cells by the inactivation of an Alu-containing silencer located at the upstream of the BRCA2 gene promoter. Possible transient epigenetic malfunction in this silencer inactivation process by environmental factors in the dividing breast cells may lead to defect in DNA repair and subsequence onset of mutations in any key gene leading to oncogenesis. We are proposing the following specific aims to test this onset of mutations in any key gene leading to oncogenesis. We are proposing the following specific aims to test this onset of mutations in any key gene leading to oncogenesis. We are proposing the following specific aims to test this BRCA2 gene promoter. (2) To characterize the silencer binding proteins from breast cell nuclear extract. (3) To evaluate the effects of transient ablation of BRCA2 gene expression in replication, mutagen sensitivity and genetic stability in dividing breast cells as compared to quiescent breast cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA091408-01
Application #
6497036
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-08-03
Project End
2006-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Meharry Medical College
Department
Type
DUNS #
City
Nashville
State
TN
Country
United States
Zip Code
37208
Wilson, Andrew J; Stubbs, Matthew; Liu, Phillip et al. (2018) The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer. Gynecol Oncol 149:575-584
Uzhachenko, Roman; Shanker, Anil; Dupont, Geneviève (2016) Computational properties of mitochondria in T cell activation and fate. Open Biol 6:
Wilson, Andrew J; Sarfo-Kantanka, Kofi; Barrack, Toby et al. (2016) Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib. Gynecol Oncol 143:143-151
Xie, Yingqiu; Lu, Wenfu; Liu, Shenji et al. (2016) MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo. Oncotarget 7:47609-47619
Pulliam, Stephanie R; Pellom Jr, Samuel T; Shanker, Anil et al. (2016) Butyrate regulates the expression of inflammatory and chemotactic cytokines in human acute leukemic cells during apoptosis. Cytokine 84:74-87
Banks, Leah D; Amoah, Priscilla; Niaz, Mohammad S et al. (2016) Olive oil prevents benzo(a)pyrene [B(a)P]-induced colon carcinogenesis through altered B(a)P metabolism and decreased oxidative damage in Apc(Min) mouse model. J Nutr Biochem 28:37-50
Pulliam, Stephanie R; Uzhachenko, Roman V; Adunyah, Samuel E et al. (2016) Common gamma chain cytokines in combinatorial immune strategies against cancer. Immunol Lett 169:61-72
Wilson, Andrew J; Fadare, Oluwole; Beeghly-Fadiel, Alicia et al. (2015) Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer. Oncotarget 6:21353-68
Korolkova, Olga Y; Myers, Jeremy N; Pellom, Samuel T et al. (2015) Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol 8:29-44
Booker, Burthia E; Clark, Ryan S; Pellom, Samuel T et al. (2015) Interleukin-34 induces monocytic-like differentiation in leukemia cell lines. Int J Biochem Mol Biol 6:1-16

Showing the most recent 10 out of 95 publications